Use this button to switch between dark and light mode.

FTC Enforcers Signal Fresh Approach to Pharma Mergers

May 11, 2021 (1 min read)

Speaking at a recent forum on pharmaceutical deals and antitrust, an adviser to acting FTC Commissioner Slaughter said that it’s time to refresh the FTC’s approach to pharma mergers.

READ NOW: Enforcers Shouldn’t Be “Bound by Past” on Theories of Merger Harm, U.S. FTC Official Says in Pharma Discussion


Related Content


Practical Guidance Updates
Featuring the latest updates in Practical Guidance.


Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+

Tags: